Kåvepenin (Phenoxymethylpenicillin Potassium)

Kåvepenin is a penicillin antibacterial used to treat infections caused by susceptible bacteria in the respiratory, skin and dental areas.

• Acute streptococcal pharyngitis: reduces throat pain and bacterial load, shortening illness duration.
• Mild to moderate skin and soft‑tissue infections: eradicates causative organisms, promoting healing of cellulitis or impetigo.
• Respiratory tract infections (e.g., otitis media, sinusitis): clears infection and alleviates associated symptoms.
• Dental infections: eliminates oral bacterial pathogens, supporting recovery after dental procedures.

• Phenoxymethylpenicillin potassium exerts its antibacterial effect by binding to penicillin‑binding proteins on the bacterial cell wall, inhibiting the transpeptidation step of peptidoglycan synthesis. After oral absorption, therapeutic concentrations are achieved in tissues and fluids. By blocking the transpeptidase enzymes, the drug prevents cross‑linking of peptidoglycan strands, leading to cell‑wall instability and osmotic lysis of susceptible Gram‑positive organisms.

Phenoxymethylpenicillin potassium may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Nausea: mild gastrointestinal upset.
• Diarrhea: loose stools, usually self‑limiting.
• Rash: mild skin erythema.
• Vaginal candidiasis: yeast overgrowth in some women.

Serious or Rare Side Effects

• Anaphylaxis: severe, potentially life‑threatening allergic reaction.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Clostridioides difficile infection: severe colitis following disruption of gut flora.

When prescribing Phenoxymethylpenicillin potassium, clinicians should consider several precautions to ensure safe use.

• Allergy assessment: avoid in patients with known penicillin hypersensitivity.
• Renal function: adjust dose in severe renal impairment.
• Hepatic disease: use with caution in patients with liver dysfunction.
• Concomitant oral contraceptives: may reduce efficacy, advise additional contraception.
• Pregnancy and lactation: evaluate risk‑benefit; limited data available.
• Store at room temperature: keep below 25 °C, protect from moisture and light in original packaging.

Phenoxymethylpenicillin potassium can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Methotrexate: increased toxicity due to reduced renal clearance.
• Oral anticoagulants (warfarin): enhanced anticoagulant effect, monitor INR closely.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: decreased plasma levels, may reduce contraceptive effectiveness.
• Probenecid: reduces renal excretion, increasing penicillin concentrations.
• Tetracyclines: antagonistic effect, may diminish antibacterial activity.